Fulgent Genetics Inc (NASDAQ: FLGT) is -21.96% lower on its value in year-to-date trading and has touched a low of $18.91 and a high of $33.97 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The FLGT stock was last observed hovering at around $23.12 in the last trading session, with the day’s loss setting it -0.56%.
Currently trading at $22.56, the stock is -4.53% and 1.27% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.14 million and changing -2.42% at the moment leaves the stock -4.46% off its SMA200. FLGT registered -32.80% loss for a year compared to 6-month gain of -2.93%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -4.29% loss in the last 1 month and extending the period to 3 months gives it a 9.25%, and is -5.21% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.75% over the week and 4.13% over the month.
Fulgent Genetics Inc (FLGT) has around 1184 employees, a market worth around $683.57M and $290.70M in sales. Profit margin for the company is -56.22%. Distance from 52-week low is 19.30% and -33.59% from its 52-week high. The company has generated returns on investments over the last 12 months (-14.30%).
The EPS is expected to grow by 3.90% this year.
Fulgent Genetics Inc (FLGT) Top Institutional Holders
263.0 institutions hold shares in Fulgent Genetics Inc (FLGT), with institutional investors hold 76.12% of the company’s shares. The shares outstanding are 29.65M, and float is at 19.60M with Short Float at 3.57%. Institutions hold 51.74% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 3.92 million shares valued at $76.93 million. The investor’s holdings represent 13.1717% of the FLGT Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 1.44 million shares valued at $$28.16 million to account for 4.8219 of the shares outstanding. The other top investors are DIMENSIONAL FUND ADVISORS LP which holds 1.22 million shares representing 4.0856% and valued at over $23.86 million, while WELLS FARGO & COMPANY/MN holds 3.3592 of the shares totaling 1.0 million with a market value of $19.62 million.
Fulgent Genetics Inc (FLGT) Insider Activity
The most recent transaction is an insider sale by Gao Hanlin,the company’sChief Scientific Officer. SEC filings show that Gao Hanlin sold 563 shares of the company’s common stock on Aug 27 ’24 at a price of $22.83 per share for a total of $12855.0. Following the sale, the insider now owns 0.92 million shares.
Fulgent Genetics Inc disclosed in a document filed with the SEC on Aug 27 ’24 that Xie Jian (President and COO) sold a total of 715 shares of the company’s common stock. The trade occurred on Aug 27 ’24 and was made at $22.83 per share for $16326.0. Following the transaction, the insider now directly holds 0.34 million shares of the FLGT stock.
Still, SEC filings show that on Aug 27 ’24, Hsieh Ming (Chief Executive Officer) disposed off 2,313 shares at an average price of $22.83 for $52813.0. The insider now directly holds 707,275 shares of Fulgent Genetics Inc (FLGT).
